Wide support found for insurance coverage for oral contraceptives

Article

Three-quarters of American consumers think that private and government-subsidized health insurance plans should cover most or all of the cost of oral contraceptives, according to a May 2011 Thomson Reuters-National Public Radio (NPR) Health Poll.

Three-quarters of American consumers think that private and government-subsidized health insurance plans should cover most or all of the cost of oral contraceptives, according to a May 2011 Thomson Reuters-National Public Radio (NPR) Health Poll.

Of 3,014 respondents interviewed between April 1 and April 13, 2011, 76.6% supported private health insurance coverage, and 74.4% support government-subsidized coverage. In addition, 78.3% said the federal government should subsidize birth control and other family planning services, excluding abortion, at government-funded clinics for low-income women. The margin of error for the poll was 1.8%.

Support for private insurance and government-subsidized coverage of oral contraceptives was high across all age, income, and education groups. For private insurance, support ranged from 61.5% among people older than 65 years to 82.8% in those younger than 35 years; from 70.6% among respondents with yearly incomes below $25,000 to 81.2% among people with incomes above $100,000; and from 70.5% for respondents with a high school education or less to 79.3% among those with education beyond the college level. For government-subsidized coverage, support ranged from 59.4% among people older than 65 years to 78.8% among people younger than 35 years; from 65.6% among respondents with annual incomes under $25,000 to 79.4% among people with incomes between $50,000 and $100,000; and from 68.5% among respondents with a high school education or less to 77.8% among respondents with education beyond the college level.

Support for birth control and other family planning services, except abortion, at government-funded clinics for low-income women was also high across the board, with the lowest approval rating at 69.7% among people older than 65 years. Approval ratings for all other groups were 73% or higher.

The poll was developed by Thomson Reuters and NPR as part of a monthly series to sample opinions on a variety of healthcare issues. Complete survey results are available at www.factsforhealthcare.com/pressroom/NPR_report_OralContraceptives.pdf.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Recent Videos
Ousseny Zerbo, PhD, highlights benefits of influenza vaccination during pregnancy | Image Credit: divisionofresearch.kaiserpermanente.org.
Michael Ussher, PhD, highlights the benefits of vaping over smoking in pregnancy | Image Credit: sgul.ac.uk.
Neal Barnard, MD, FACC, highlights AMA's new breast cancer prevention guidelines | Image Credit: pcrm.org.
Zachary Wagner, PhD, discusses the harms of bias in reproductive care | Image Credit: ornsife.usc.edu.
Related Content
© 2025 MJH Life Sciences

All rights reserved.